Publication: Laparoscopic Adjustable Gastric Banding and Hypoglycemia
Open/View Files
Date
2013
Published Version
Journal Title
Journal ISSN
Volume Title
Publisher
Hindawi Publishing Corporation
The Harvard community has made this article openly available. Please share how this access benefits you.
Citation
Bairdain, Sigrid, Mark Cleary, Chueh Lien, Ashley H. Vernon, Bradley C. Linden, and David B. Lautz. 2013. “Laparoscopic Adjustable Gastric Banding and Hypoglycemia.” Case Reports in Endocrinology 2013 (1): 671848. doi:10.1155/2013/671848. http://dx.doi.org/10.1155/2013/671848.
Research Data
Abstract
Obesity is commonplace, and surgical treatment usually includes Roux-en-Y gastric bypasses (RYGBs). RYGBs have the most documented side effects including vitamin deficiencies, rebound weight gain, and symptomatic hypoglycemia; fewer series exist describing hypoglycemia following other bariatric operations. We reviewed all patients undergoing laparoscopic adjustable gastric banding (LAGB) at our institution between 2008 and 2012. Three patients were identified to have symptomatic hypoglycemia following LAGB. Mean time from surgery was 33 months (range 14–45 months), and mean weight loss was 32.7 kg (range 15.9–43.1 kg). None of the patients had preexisting diabetes. Therefore, symptomatic hypoglycemia should be investigated irrespective of bariatric operation.
Description
Other Available Sources
Keywords
Terms of Use
This article is made available under the terms and conditions applicable to Other Posted Material (LAA), as set forth at Terms of Service